- Advertisement -[the_ad id="1761"] [the_ad id="5849"] [the_ad id="7842"]
Home News Company News NOVOGEN bolsters upper management to match increased growth

NOVOGEN bolsters upper management to match increased growth

The development of the NOVOGEN teams continues with the arrival of Stéphane Lemoine as Deputy Director, Head of Business Development.

Stéphane Lemoine

With this new arrival within the team, the GRIMAUD Group subsidiary, a specialist in poultry egg selection, is now ready to go full steam ahead in the development of its commercial presence, all the while supporting Mickaël LE HELLOCO as Managing Director.
Formerly Managing Director of Nutrilia and then Director of MixScience Export within the Avril Group, Stéphane Lemoine demonstrates enduring international experience in the animal production sectors.
His in-depth knowledge of several markets including Asia, the Middle East, and Eastern Europe is a major asset and provides a real opportunity for us to strengthen our presence within these markets, says Mickaël LE HELLOCO, Managing Director of NOVOGEN. The reorganisation of our operational teams persists, allowing us to continue satisfying our customers as best possible, which is of utmost importance to us!
NOVOGEN and its technical sales teams will be present at upcoming international exhibitions, including IPPE in Atlanta and VIV ASIA in Bangkok. This will give us the opportunity to discuss the sector’s future and to present NOVOGEN’s major R&D investment plan, establishing its place as a leader in egg selection.

About Novogen:
Novogen is a major player in genetic egg selection. Established in 2008, it is present in over 50 countries with subsidiaries located in the United States and Brazil, and a partnership with Verbeek in the Netherlands.
Novogen is an entity of the Grimaud Group, its head office is located in Plédran (Côtes-d’Armor Department).
For more information: www.novogen-layers.com

About the Grimaud Group:
The Grimaud Group is a world leader in multi-species animal genetics and human and animal biopharmaceuticals. It is present in over 100 countries, generates €310 million in turnover, and employs 1,800 people globally.
The group is primarily family-owned and its head office is located in Sèvremoine (Maine-et-Loire Department).
For more information: www.grimaud.com

Exit mobile version